| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,078 |
5,357 |
$849K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,182 |
6,448 |
$600K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,983 |
1,747 |
$389K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,203 |
1,054 |
$61K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,633 |
2,141 |
$60K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,146 |
1,814 |
$48K |
| 80053 |
Comprehensive metabolic panel |
8,075 |
6,814 |
$46K |
| 80050 |
General health panel |
1,089 |
985 |
$41K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
511 |
409 |
$41K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
9,943 |
8,191 |
$40K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
79 |
69 |
$36K |
| 71045 |
Radiologic examination, chest; single view |
925 |
816 |
$26K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
745 |
608 |
$25K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
840 |
746 |
$23K |
| 71046 |
Radiologic examination, chest; 2 views |
797 |
717 |
$21K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
69 |
62 |
$18K |
| 80061 |
Lipid panel |
1,720 |
1,574 |
$18K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
639 |
579 |
$15K |
| 36415 |
Collection of venous blood by venipuncture |
6,580 |
5,284 |
$10K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,270 |
1,164 |
$10K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
220 |
186 |
$9K |
| 70450 |
Computed tomography, head or brain; without contrast material |
65 |
56 |
$9K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
480 |
353 |
$9K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
19 |
16 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
693 |
597 |
$8K |
| 82607 |
|
600 |
555 |
$8K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
77 |
39 |
$7K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
334 |
286 |
$5K |
| 83880 |
|
282 |
251 |
$5K |
| 81003 |
|
3,624 |
3,112 |
$5K |
| 84484 |
|
799 |
666 |
$5K |
| 83735 |
|
983 |
887 |
$5K |
| 84439 |
|
583 |
537 |
$4K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
162 |
135 |
$4K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
83 |
72 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
269 |
234 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
119 |
105 |
$3K |
| 81025 |
|
358 |
312 |
$2K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
43 |
40 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
29 |
29 |
$2K |
| J2704 |
Injection, propofol, 10 mg |
1,125 |
876 |
$2K |
| 93041 |
|
49 |
44 |
$2K |
| J3490 |
Unclassified drugs |
572 |
313 |
$2K |
| 82553 |
|
320 |
277 |
$2K |
| 94762 |
|
38 |
38 |
$2K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
34 |
33 |
$1K |
| 82550 |
|
304 |
263 |
$871.38 |
| 83690 |
|
148 |
132 |
$674.03 |
| 87400 |
|
82 |
73 |
$663.47 |
| 84481 |
|
52 |
51 |
$652.02 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
144 |
124 |
$650.20 |
| 82746 |
|
47 |
44 |
$646.80 |
| 82150 |
|
125 |
111 |
$517.35 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
295 |
248 |
$506.47 |
| J1335 |
Injection, ertapenem sodium, 500 mg |
35 |
25 |
$431.24 |
| 81001 |
|
230 |
193 |
$390.16 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
16 |
13 |
$349.92 |
| 85730 |
|
118 |
105 |
$331.64 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
32 |
28 |
$329.43 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
26 |
22 |
$325.40 |
| 84436 |
|
54 |
51 |
$289.52 |
| 85610 |
|
123 |
109 |
$252.76 |
| 83540 |
|
53 |
49 |
$252.33 |
| 83550 |
|
27 |
27 |
$231.77 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
16 |
16 |
$230.01 |
| 87449 |
|
19 |
16 |
$204.20 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
44 |
39 |
$201.75 |
| 84443 |
Thyroid stimulating hormone (TSH) |
18 |
15 |
$156.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
135 |
94 |
$155.10 |
| 80178 |
|
29 |
28 |
$138.81 |
| 87070 |
|
14 |
13 |
$129.09 |
| 87040 |
|
16 |
13 |
$103.20 |
| 83605 |
|
16 |
12 |
$80.99 |
| 83874 |
|
15 |
12 |
$52.52 |
| 94664 |
|
15 |
12 |
$0.00 |